Drug Trial Radar · NCT05419869
Pilot Decentralized Trial
Last checked: Nov 20, 2026Latest source record: Jan 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Jun 1, 2022
Primary completion
Jan 13, 2023
Study completion Jan 26, 2023
Sponsor
- Lead sponsor
- Alto NeuroscienceIndustry
- Sponsor type
- Industry
- First posted
- Jun 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-100.
Conditions
- Major Depressive Disorder
Interventions
ALTO-100 PO TabletDrug
Two tablets daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- To understand the relationship between baseline biology and score change in the Montgomery-Asberg Depression Rating Scale (MADRS) with ALTO-100 from start of dosing to end of treatmentTime frame: Measured at Day 1, Day 14, Day 28, Day 42, Day 56
- To understand the relationship between baseline biology and score change in the Clinical Global Impression scale - Severity (CGI-S) with ALTO-100 from Screening to end of treatmentTime frame: Measured at Screening, Day 1, Day 14, Day 28, Day 42, Day 56
- Number of Participants with Adverse Events (AEs) as a Measure of Safety and Tolerability of ALTO-100Time frame: From the signing of the ICF until the follow-up visit (up to 13 weeks)
- Number of Participants With Clinically Significant Laboratory Abnormalities as a Measure of Safety and Tolerability of ALTO-100Time frame: From the signing of the ICF until the end-of-treatment visit (up to 13 weeks)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Site 160
Coral Gables, Florida
Site 156
Jackson, Mississippi
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.